Literature DB >> 21557758

The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression.

Stephen E Kimmel1, Hedi Schelleman, Jesse A Berlin, David W Oslin, Rachel B Weinstein, Judith L Kinman, William H Sauer, James D Lewis.   

Abstract

AIM: To evaluate whether selective serotonin re-uptake inhibitor (SSRI) exposure influences the risk of myocardial infarction (MI) in patients with depression.
METHODS: This study included 693 patients with MI (cases) and 2772 controls. Conditional logistic regression was used to calculate the odds ratio (OR).
RESULTS: SSRI exposure may be associated with a reduced MI risk (OR = 0.77, 95% CI 0.57, 1.03). However, reduced risk was only observed with longer term use (OR = 0.73, 95% CI 0.53, 1.00) and not with shorter term use (OR = 1.15, 95% CI: 0.65, 2.05).
CONCLUSIONS: Only longer term use of SSRIs was associated with reduced MI risk, suggesting that other mechanisms, besides an acute anti-platelet effect, may reduce MI risk.
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21557758      PMCID: PMC3175522          DOI: 10.1111/j.1365-2125.2011.04008.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.

Authors:  C R Meier; R G Schlienger; H Jick
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

2.  Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.

Authors:  Raymond G Schlienger; Lorenz M Fischer; Hershel Jick; Christoph R Meier
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

3.  A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population.

Authors:  Christopher M Blanchette; Linda Simoni-Wastila; Ilene H Zuckerman; Bruce Stuart
Journal:  Ann Epidemiol       Date:  2008-02-08       Impact factor: 3.797

4.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

5.  Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study.

Authors:  C van Walraven; M M Mamdani; P S Wells; J I Williams
Journal:  BMJ       Date:  2001-09-22

6.  Platelet reactivity in depressed patients treated with paroxetine: preliminary findings.

Authors:  D L Musselman; U M Marzec; A Manatunga; S Penna; A Reemsnyder; B T Knight; A Baron; S R Hanson; C B Nemeroff
Journal:  Arch Gen Psychiatry       Date:  2000-09

7.  Paroxetine decreases platelet serotonin storage and platelet function in human beings.

Authors:  N Hergovich; M Aigner; H G Eichler; J Entlicher; C Drucker; B Jilma
Journal:  Clin Pharmacol Ther       Date:  2000-10       Impact factor: 6.875

8.  Selective serotonin reuptake inhibitors and myocardial infarction.

Authors:  W H Sauer; J A Berlin; S E Kimmel
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

9.  Depression is a risk factor for coronary artery disease in men: the precursors study.

Authors:  D E Ford; L A Mead; P P Chang; L Cooper-Patrick; N Y Wang; M J Klag
Journal:  Arch Intern Med       Date:  1998-07-13

10.  General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.

Authors:  L J Tata; J West; C Smith; P Farrington; T Card; L Smeeth; R Hubbard
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

View more
  17 in total

Review 1.  Using human experience to identify drug repurposing opportunities: theory and practice.

Authors:  D Cavalla
Journal:  Br J Clin Pharmacol       Date:  2019-02-03       Impact factor: 4.335

2.  Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies.

Authors:  A Biffi; L Scotti; G Corrao
Journal:  Eur J Clin Pharmacol       Date:  2017-01-09       Impact factor: 2.953

Review 3.  Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.

Authors:  Bernardo Sousa-Pinto; Manuel J Ferreira-Pinto; Mário Santos; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

4.  Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies.

Authors:  Seung-Won Oh; Joonseok Kim; Seung-Kwon Myung; Seung-Sik Hwang; Dae-Hyun Yoon
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

5.  Clinical depression, antidepressant use and risk of future cardiovascular disease.

Authors:  Iffat Rahman; Keith Humphreys; Anna Michaela Bennet; Erik Ingelsson; Nancy Lee Pedersen; Patrik Karl Erik Magnusson
Journal:  Eur J Epidemiol       Date:  2013-07-09       Impact factor: 8.082

6.  Differential effects of antidepressant subgroups on risk of acute myocardial infarction: A nested case-control study.

Authors:  Rasha Alqdwah-Fattouh; Sara Rodríguez-Martín; Francisco J de Abajo; Diana González-Bermejo; Miguel Gil; Alberto García-Lledó; Francisco Bolúmar
Journal:  Br J Clin Pharmacol       Date:  2020-05-09       Impact factor: 4.335

7.  Functional constituents of a local serotonergic system, intrinsic to the human coronary artery smooth muscle cells.

Authors:  Kannan Baskar; Swastika Sur; Vithyalakshmi Selvaraj; Devendra K Agrawal
Journal:  Mol Biol Rep       Date:  2015-04-11       Impact factor: 2.316

Review 8.  Anxiety Disorders and Cardiovascular Disease.

Authors:  Christopher M Celano; Daniel J Daunis; Hermioni N Lokko; Kirsti A Campbell; Jeff C Huffman
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

9.  Selective serotonin reuptake inhibitors and endothelial function in women.

Authors:  Liisa Hantsoo; Kathryn A Czarkowski; Josiah Child; Christopher Howes; C Neill Epperson
Journal:  J Womens Health (Larchmt)       Date:  2014-06-02       Impact factor: 2.681

10.  Peripheral microvascular serotoninergic signaling is dysregulated in young adults with major depressive disorder.

Authors:  Jody L Greaney; Gabrielle A Dillon; Erika F H Saunders; Lacy M Alexander
Journal:  J Appl Physiol (1985)       Date:  2019-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.